기분조절제로 인한 인지기능 부작용이 동반된 양극성 기분장애 환자의 임상적인 특징: 아시아의 정신작용약물 처방 경향 연구(REAP-BD Survey) 중 국내 자료 활용|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Objectives This study aimed to identify differences between bipolar disorder patients who experienced cognitive side effects and those who did not experience cognitive side effects due to prescription of mood stabilizers.
Methods This study analyzed 350 Korean adults who were diagnosed with bipolar disorder and prescribed mood-stabilizing drugs. The patients were divided into two groups—patients who experienced cognitive side effects and those who did not experience cognitive side effects.
We also compared the demographic and clinical characteristics between both groups.
Results The number of patients with an untreated illness longer than 1 year was higher in the group of patients who experienced cognitive side effects compared to the group of patients who did not experience cognitive side effects. Further, the number of patients with manic symptoms at onset was higher in the group of patients who experienced cognitive side effects compared to the group of patients who did not experience cognitive side effects. In addition, the proportion of patients in remission was higher in the group of patients who experienced cognitive side effects compared to the group of patients who experienced no cognitive side effects. However, there was no significant difference regarding the type of mood stabilizer used between the groups. On the other hand, more people experienced cognitive side effects as the valproic acid dosage increased.
Conclusion Our findings suggest that there are clinical and demographic differences between people who experienced cognitive side effects and those who did not experience cognitive side effects due to prescription of mood stabilizers.

번역하기

참고문헌 (Reference)

1 Bora E, "The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients" 9 : 468-477, 2007

2 Campbell N, "The cognitive impact of anticholinergics : a clinical review" 4 : 225-233, 2009

3 World Health Organization, "The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines" World Health Organization 1992

4 Fellinger M, "Seasonality in bipolar disorder : effect of sex and age" 243 : 322-326, 2019

5 Bauer IE, "Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder : a diffusion tensor imaging study" 62 : 115-122, 2015

6 Wollenhaupt-Aguiar B, "Reduced neurite density in neuronal cell cultures exposed to serum of patients with bipolar disorder" 19 : pyw051-, 2016

7 Stellos K, "Predictive value of platelet activation for the rate of cognitive decline in Alzheimer’s disease patients" 30 : 1817-1820, 2010

8 Perugi G, "Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients" 41 : 13-18, 2000

9 Young AH, "Physical health of patients with bipolar disorder" 127 : 3-10, 2013

10 Dias VV, "Pharmacological approaches in bipolar disorders and the impact on cognition : a critical overview" 126 : 315-331, 2012